RxDoctor Payments Data

Walter Bruning

Internal Medicine · Louisville, KYNPI 1063419901

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.8% of the total across 659 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 52 manufacturers, the largest accounting for just 11.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $5,268 and has fallen 70.5% since, to $1,555 in 2024. Among internal medicine clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$21,535in general payments, 2019–2025

Across 659 payments — averaging $32.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • Amgen$2K
  • AbbVie$2K
  • GSK$2K
  • Johnson & Johnson$1K
  • Novartis$1K
  • plus $11K from 46 others

What the payments were for

  • Food & beverage$21,502100%
  • Education$330%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,535 in reported general payments places this provider in the 95th percentile of 1,284 internal medicine providers in Kentucky.

See all internal medicine providers in Kentucky

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban37$33,758
XareltoRivaroxaban16$20,302
JardianceEmpagliflozin11$18,887
JanuviaSitagliptin Phosphate11$16,464
FarxigaDapagliflozin Propanediol14$12,369
Atorvastatin Calcium262$2,050
Ezetimibe45$1,872
SynthroidLevothyroxine Sodium34$1,693
Metoprolol Succinate62$1,325
Levothyroxine Sodium99$1,139
Rosuvastatin Calcium92$1,068
Potassium Chloride41$963
RivastigmineRivastigmine Tartrate11$761
Losartan Potassium66$681
Pravastatin Sodium68$607

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$1,021$33,75837 claims
Johnson & JohnsonXarelto$1,448$20,30216 claims
Boehringer IngelheimJardiance$1,132$18,88711 claims
MerckJanuvia$380$16,46411 claims
AstraZenecaFarxiga$2,369$12,36914 claims
AbbVieSynthroid$1,665$1,69334 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,284 internal medicine providers in Kentucky.

Other internal medicine in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →